Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma:... von Guimbaud, Rosine, Louvet, Christophe, Ries, Pauline, Ychou, Marc, Maillard, Emilie, André, Thierry, Gornet, Jean-Marc, Aparicio, Thomas, Nguyen, Suzanne, Azzedine, Ahmed, Etienne, Pierre-Luc, Boucher, Eveline, Rebischung, Christine, Hammel, Pascal, Rougier, Philippe, Bedenne, Laurent, Bouché, Olivier

Volltext

Capecitabine plus oxaliplatin (XELOX) versus 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) as first‐line treatment for metastatic colorectal cancer von Ducreux, Michel, Bennouna, Jaafar, Hebbar, Mohamed, Ychou, Marc, Lledo, Gérard, Conroy, Thierry, Adenis, Antoine, Faroux, Roger, Rebischung, Christine, Bergougnoux, Loic, Kockler, Leila, Douillard, Jean‐Yves

Volltext

Recommendations for Bowel Obstruction With Peritoneal Carcinomatosis von Laval, Guillemette, MD, Marcelin-Benazech, Blandine, MD, Guirimand, Frédéric, MD, Chauvenet, Laure, MD, Copel, Laure, MD, Durand, Aurélie, MD, Francois, Eric, MD, Gabolde, Martine, MD, Mariani, Pascale, MD, Rebischung, Christine, MD, Servois, Vincent, MD, Terrebonne, Eric, MD, Arvieux, Catherine, MD

Volltext

Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial von Hammel, Pascal, Fabienne, Portales, Mineur, Laurent, Metges, Jean-Philippe, Andre, Thierry, De La Fouchardiere, Christelle, Louvet, Christophe, El Hajbi, Farid, Faroux, Roger, Guimbaud, Rosine, Tougeron, David, Bouche, Olivier, Lecomte, Thierry, Rebischung, Christine, Tournigand, Christophe, Cros, Jerome, Kay, Richard, Hamm, Adam, Gupta, Anu, Bachet, Jean-Baptiste, El Hariry, Iman

Volltext

The effectiveness of trastuzumab (Herceptin) combined with chemotherapy for gastric carcinoma with overexpression of the c-erbB-2 protein von Rebischung, Christine, Barnoud, Raphaëlle, Stéfani, Laetitia, Faucheron, Jean-Luc, Mousseau, Mireille

Volltext

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort von Walter, T, Tougeron, D, Baudin, E, Le Malicot, K, Lecomte, T, Malka, D, Hentic, O, Manfredi, S, Bonnet, I, Guimbaud, R, Coriat, R, Lepère, C, Desauw, C, Thirot-Bidault, A, Dahan, L, Roquin, G, Aparicio, T, Legoux, J.-L, Lombard-Bohas, C, Scoazec, J.-Y, Lepage, C, Cadiot, G

Volltext

Prognostic value of P53 mutations in rectal carcinoma von Rebischung, Christine, Gérard, Jean‐Pierre, Gayet, Jacqueline, Thomas, Gilles, Hamelin, Richard, Laurent‐Puig, Pierre

Volltext

A Randomized Phase II Trial of Three Intensified Chemotherapy Regimens in First-Line Treatment of Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable... von Ychou, Marc, Rivoire, Michel, Thezenas, Simon, Quenet, François, Delpero, Jean-Robert, Rebischung, Christine, Letoublon, Christian, Guimbaud, Rosine, Francois, Eric, Ducreux, Michel, Desseigne, Françoise, Fabre, Jean-Michel, Assenat, Eric

Volltext

Erratum to ‘Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb... von Hammel, Pascal, Portales, Fabienne, Mineur, Laurent, Metges, Jean-Philippe, Andre, Thierry, De La Fouchardiere, Christelle, Louvet, Christophe, El Hajbi, Farid, Faroux, Roger, Guimbaud, Rosine, Tougeron, David, Bouche, Olivier, Lecomte, Thierry, Rebischung, Christine, Tournigand, Christophe, Cros, Jerome, Kay, Richard, Hamm, Adam, Gupta, Anu, Bachet, Jean-Baptiste, El Hariry, Iman

Volltext

Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study von Palle, Juliette, Tougeron, David, Pozet, Astrid, Soularue, Emilie, Artru, Pascal, Leroy, Florence, Dubreuil, Olivier, Sarabi, Matthieu, Williet, Nicolas, Manfredi, Sylvain, Martin-Babau, Jerome, Rebischung, Christine, Abdelghani, Meher Ben, Evesque, Ludovic, Dreanic, Johann, Hautefeuille, Vincent, Louafi, Samy, Sefrioui, David, Savinelli, Francesco, Mabro, May, Rousseau, Benoit, Lecaille, Cédric, Bouché, Olivier, Louvet, Christophe, Lecomte, Thierry, Bonnetain, Franck, Taieb, Julien, Zaanan, Aziz

Volltext

FOLFIRINOX until progression, FOLFIRINOX with maintenance treatment, or sequential treatment with gemcitabine and FOLFIRI.3 for first-line treatment of metastatic pancreatic cancer... von Dahan, Laetitia, Phelip, Jean Marc, Le Malicot, Karine, Williet, Nicolas, Desrame, Jérôme, Volet, Julien, Petorin, Caroline, Malka, David, Rebischung, Christine, Aparicio, Thomas, Lecaille, Cedric, Rinaldi, Yves, Turpin, Anthony, Bignon, Anne Laure, Bachet, Jean-Baptiste, Seitz, Jean Francois, Lepage, Come, Francois, Eric

Volltext

Germ cell tumors in patients infected by the human immunodeficiency virus von Fizazi, Karim, Amato, Robert J., Beuzeboc, Philippe, Petit, Nathalie, Bouhour, Damien, Thiss, Antoine, Rebischung, Christine, Chevreau, Christine, Logothetis, Christopher J., Droz, Jean‐Pierre

Volltext

PRODIGE 52-UCGI 29-CCTG/CO.27 (IROCAS): A multicenter, international, randomized phase III trial comparing adjuvant modified (m)FOLFIRINOX to mFOLFOX6 in patients with high-risk st... von Bennouna, Jaafar, Andre, Thierry, Miglianico, Laurent, Campion, Loic, Mineur, Laurent, Lam, You Heng, Hiret, Sandrine, Artru, Pascal, Bouche, Olivier, Borde, Florence, Aleba, Albert, Rajpar, Laetitia-Shanna, Rebischung, Christine, Touchefeu, Yann, Kavan, Petr, Gill, Sharlene, Asmis, Tim, Jouffroy-Zeller, Claire, Emile, Jean-François, Taieb, Julien

Volltext

Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer von Gaudet, Mia M, Kirchhoff, Tomas, Green, Todd, Vijai, Joseph, Korn, Joshua M, Guiducci, Candace, Segrè, Ayellet V, McGee, Kate, McGuffog, Lesley, Kartsonaki, Christiana, Morrison, Jonathan, Healey, Sue, Sinilnikova, Olga M, Stoppa-Lyonnet, Dominique, Mazoyer, Sylvie, Gauthier-Villars, Marion, Sobol, Hagay, Longy, Michel, Frenay, Marc, GEMO Study Collaborators, Hogervorst, Frans B L, Rookus, Matti A, Collée, J Margriet, Hoogerbrugge, Nicoline, van Roozendaal, Kees E P, Piedmonte, Marion, Rubinstein, Wendy, Nerenstone, Stacy, Van Le, Linda, Blank, Stephanie V, Caldés, Trinidad, de la Hoya, Miguel, Nevanlinna, Heli, Aittomäki, Kristiina, Lazaro, Conxi, Blanco, Ignacio, Arason, Adalgeir, Johannsson, Oskar T, Barkardottir, Rosa B, Devilee, Peter, Olopade, Olofunmilayo I, Neuhausen, Susan L, Wang, Xianshu, Fredericksen, Zachary S, Peterlongo, Paolo, Manoukian, Siranoush, Barile, Monica, Viel, Alessandra, Radice, Paolo, Phelan, Catherine M, Narod, Steven, Rennert, Gad, Lejbkowicz, Flavio, Flugelman, Anath, Andrulis, Irene L, Glendon, Gord, Ozcelik, Hilmi, Toland, Amanda E, Montagna, Marco, D'Andrea, Emma, Friedman, Eitan, Laitman, Yael, Borg, Ake, Beattie, Mary, Ramus, Susan J, Domchek, Susan M, Nathanson, Katherine L, Rebbeck, Tim, Spurdle, Amanda B, Chen, Xiaoqing, Holland, Helene, John, Esther M, Hopper, John L, Buys, Saundra S, Daly, Mary B, Southey, Melissa C, Terry, Mary Beth, Tung, Nadine, Overeem Hansen, Thomas V, Nielsen, Finn C, Greene, Mark H, Greene, Mark I, Mai, Phuong L, Osorio, Ana, Durán, Mercedes, Andres, Raquel, Benítez, Javier, Weitzel, Jeffrey N, Garber, Judy, Hamann, Ute, Peock, Susan, Cook, Margaret, Oliver, Clare, Frost, Debra, Platte, Radka, Evans, D Gareth, Lalloo, Fiona, Eeles, Ros, Izatt, Louise, Walker, Lisa

Volltext

Chemotherapy in Patients with Teratoma with Malignant Transformation von El Mesbahi, Omar, Terrier-Lacombe, Marie-Josée, Rebischung, Christine, Theodore, Christine, Vanel, Daniel, Fizazi, Karim

Volltext

CAG repeat size in Huntingtin alleles is associated with cancer prognosis von Thion, Morgane Sonia, Tézenas du Montcel, Sophie, Golmard, Jean-Louis, Vacher, Sophie, Barjhoux, Laure, Sornin, Valérie, Cazeneuve, Cécile, Bièche, Ivan, Sinilnikova, Olga, Stoppa-Lyonnet, Dominique, Durr, Alexandra, Humbert, Sandrine

Volltext

A phase IIb of eryaspase in combination with gemcitabine or FOLFOX as second-line therapy in patients with metastatic pancreatic adenocarcinoma (NCT02195180) von Hammel, Pascal, Bachet, Jean-Baptiste, El-Hariry, Iman, Portales, Fabienne, Mineur, Laurent, Metges, Jean-Philippe, De La Fouchardiere, Christelle, Louvet, Christophe, El Hajbi, Farid, Faroux, Roger, Guimbaud, Rosine, Tougeron, David, Volet, Julien, Lecomte, Thierry, Tournigand, Christophe, Rebischung, Christine, Berlier, Willy, Gupta, Anu, Cros, Jerome, Andre, Thierry

Volltext

Management of Patients with Pancreatic Ductal Adenocarcinoma in the Real-Life Setting: Lessons from the French National Hospital Database von de la Fouchardière, Christelle, Adham, Mustapha, Marion-Audibert, Anne-Marie, Duclos, Antoine, Darcha, Claude, Berthelet, Olivier, Hervieu, Valérie, Artru, Pascal, Labrosse, Hélène, Fayet, Yohan, Ferroud-Plattet, Bruno, Aublet-Cuvellier, Bruno, Chambon, Georges, Baconnier, Mathieu, Rebischung, Christine, Farsi, Fadila, Ray-Coquard, Isabelle, Mastier, Charles, Ternamian, Pierre-Jean, Williet, Nicolas, Buc, Emmanuel, Walter, Thomas, Herr, Andrée-Laure

Volltext

Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: A multicenter AGEO study von Palle, Juliette, Tougeron, David, Pozet, Astrid, Soularue, Emilie, Artru, Pascal, Le Roy, Florence, Dubreuil, Olivier, Sarabi, Matthieu, Williet, Nicolas, Manfredi, Sylvain, Martin-Babau, Jerome, Rebischung, Christine, Ben Abdelghani, Meher, Evesque, Ludovic, Dreanic, Johann, Hautefeuille, Vincent, Louvet, Christophe, Lecomte, Thierry, Taïeb, Julien, Zaanan, Aziz

Volltext

The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers von Garcia, Amandine I., Cox, David G., Barjhoux, Laure, Verny-Pierre, Carole, Barnes, Daniel, Antoniou, Antonis C., Stoppa-Lyonnet, Dominique, Sinilnikova, Olga M., Mazoyer, Sylvie

Volltext